BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29351307)

  • 1. Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice.
    Merentie M; Rissanen R; Lottonen-Raikaslehto L; Huusko J; Gurzeler E; Turunen MP; Holappa L; Mäkinen P; Ylä-Herttuala S
    PLoS One; 2018; 13(1):e0190981. PubMed ID: 29351307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
    Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
    Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible and reversible lentiviral and Recombination Mediated Cassette Exchange (RMCE) systems for controlling gene expression.
    Bersten DC; Sullivan AE; Li D; Bhakti V; Bent SJ; Whitelaw ML
    PLoS One; 2015; 10(3):e0116373. PubMed ID: 25768837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline-dependent inducible and reversible RNA interference mediated by a single lentivirus vector.
    Matsushita N; Matsushita S; Hirakawa S; Higashiyama S
    Biosci Biotechnol Biochem; 2013; 77(4):776-81. PubMed ID: 23563548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor A expression in mouse granulosa cells by lentivector-mediated RNAi.
    Ally N; Zou XL; Jiang BC; Qin L; Zhai L; Xiao P; Liu HL
    Genet Mol Res; 2012 Nov; 11(4):4019-33. PubMed ID: 23212339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
    Frank SB; Schulz VV; Miranti CK
    BMC Biotechnol; 2017 Feb; 17(1):24. PubMed ID: 28245848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.
    Zhang X; Crawford R; Xiao Y
    J Mol Med (Berl); 2016 Jul; 94(7):787-98. PubMed ID: 27164955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system.
    Lachmann N; Brennig S; Pfaff N; Schermeier H; Dahlmann J; Phaltane R; Gruh I; Modlich U; Schambach A; Baum C; Moritz T
    Gene Ther; 2013 Mar; 20(3):298-307. PubMed ID: 22592598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short fish-origin DNA elements served as flanking sequences in a knockdown cloning vector enabling the generation of a functional siRNA molecule in mammalian cells and fish embryos.
    Lin CY; Lee HC; Wu JH; Tsai HJ
    Biochem Biophys Res Commun; 2018 Nov; 505(3):850-857. PubMed ID: 30301529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retro-lentiviral system for doxycycline-inducible gene expression and gene knockdown in cells with limited proliferative capacity.
    Alexeyev MF; Fayzulin R; Shokolenko IN; Pastukh V
    Mol Biol Rep; 2010 Apr; 37(4):1987-91. PubMed ID: 19655272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-Mediated RNAi Silencing of VEGF Inhibits Angiogenesis and Growth of Renal Cell Carcinoma in a Nude Mouse Xenograft Model.
    Lin J; Pang H; Guo X; Ding Y; Geng J; Zhang J; Min J
    DNA Cell Biol; 2015 Dec; 34(12):717-27. PubMed ID: 26465082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline regulated lentiviral vectors.
    Markusic D; Seppen J
    Methods Mol Biol; 2010; 614():69-76. PubMed ID: 20225036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo.
    Centlivre M; Zhou X; Pouw SM; Weijer K; Kleibeuker W; Das AT; Blom B; Seppen J; Berkhout B; Legrand N
    Gene Ther; 2010 Jan; 17(1):14-25. PubMed ID: 19727135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells.
    Lombardi G; Calistri A; Curtarello M; Giudice GL; Piermarocchi S; Prosdocimo G; Palù G; Parolin C
    Br J Ophthalmol; 2009 Feb; 93(2):244-8. PubMed ID: 19174401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
    Aagaard L; Amarzguioui M; Sun G; Santos LC; Ehsani A; Prydz H; Rossi JJ
    Mol Ther; 2007 May; 15(5):938-45. PubMed ID: 17311008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNA.
    Blosser W; Vakana E; Wyss LV; Swearingen ML; Stewart J; Stancato L; Tate CM
    PLoS One; 2014; 9(4):e96036. PubMed ID: 24759702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy.
    Turunen MP; Lehtola T; Heinonen SE; Assefa GS; Korpisalo P; Girnary R; Glass CK; Väisänen S; Ylä-Herttuala S
    Circ Res; 2009 Sep; 105(6):604-9. PubMed ID: 19696410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.